Olivia C. Ware - 04 Apr 2024 Form 3 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
Director
Signature
/s/ Peter Slover, Attorney-in-Fact
Issuer symbol
CTNM
Transactions as of
04 Apr 2024
Net transactions value
$0
Form type
3
Filing time
04 Apr 2024, 17:59:55 UTC
Previous filing
18 Mar 2024
Next filing
18 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTNM Stock Option (right to buy) 04 Apr 2024 Class A Common Stock 29,479 $16.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted under the Issuer's 2012 Equity Incentive Plan. The option shares vest and become exercisable in 24 equal monthly installments beginning on April 15, 2024 subject to the Reporting Person's continuous service.

Remarks:

Exhibit 24 - Power of Attorney